Abha B Kumar
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 19
- 4 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
19 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Abha B Kumar’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
19 of 19 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A53636 · Current
Licensed to practise in California · since 1994 · expires 2028-03-31 · University of Madras, Christian Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$20,755
Medicare paid this office $20,755 for 96 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 23 | $11,471 | $499 |
| Established patient problem focused exam of visual system | 59 | $3,179 | $37 |
| New patient problem focused exam of visual system | 14 | $465 | $33 |
| Ultrasound scan to determine eye length and lens power | 17 | $428 | $25 |
Procedures Medicare counted
| Cataract surgery | 28 | More than 52% of doctors who do this |
Who their Medicare patients are
96 Original Medicare patients in 2024. Average age 73 · Women 65% · Also on Medicaid 88% · Health risk score 1.52. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 67% · Diabetes 46% · Chronic kidney disease 17% · Depression 15% · Coronary heart disease 14% · Heart failure 11%.
The office billed $317,637, Medicare allowed $29,065 and paid $20,755; for 189 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 96 | 189 | 73 | 1.52 | $317,637 | $20,755 |
| 2023 | 91 | 191 | 74 | 1.57 | $327,898 | $23,406 |
| 2022 | 64 | 117 | 72 | 1.28 | $189,996 | $13,361 |
| 2021 | 96 | 192 | 73 | 1.42 | $379,777 | $28,931 |
| 2020 | 88 | 163 | 72 | 1.62 | $243,556 | $18,906 |
| 2019 | 140 | 274 | 71 | 1.54 | $308,644 | $28,007 |
| 2018 | 181 | 371 | 71 | 1.35 | $310,570 | $34,622 |
| 2017 | 143 | 274 | 71 | 1.51 | $196,857 | $19,887 |
| 2016 | 179 | 335 | 72 | 1.48 | $230,608 | $20,552 |
| 2015 | 155 | 300 | 71 | 1.39 | $345,326 | $32,289 |
| 2014 | 184 | 327 | 72 | 1.27 | $346,039 | $34,738 |
| 2013 | 244 | 418 | 70 | 1.25 | $411,189 | $48,188 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Removal of cataract with insertion of prosthetic lens | 21 | $11,012 | $524 |
| Established patient problem focused exam of visual system | 56 | $3,225 | $41 |
| New patient problem focused exam of visual system | 16 | $656 | $41 |
| Ultrasound scan to determine eye length and lens power | 17 | $351 | $21 |
2022: 3 services
| Removal of cataract with insertion of prosthetic lens | 18 | $9,337 | $519 |
| Established patient problem focused exam of visual system | 48 | $2,374 | $43 |
| Ultrasound scan to determine eye length and lens power | 16 | $379 | $24 |
2021: 5 services
| Removal of cataract with insertion of prosthetic lens | 29 | $15,686 | $523 |
| Established patient problem focused exam of visual system | 62 | $3,069 | $37 |
| Ultrasound scan to determine eye length and lens power | 20 | $505 | $25 |
| Exam of visual field with extended testing | 12 | $310 | $24 |
| Imaging of optic nerve | 11 | $211 | $19 |
2020: 4 services
| Removal of cataract with insertion of prosthetic lens | 17 | $9,776 | $543 |
| Established patient problem focused exam of visual system | 54 | $1,979 | $30 |
| Ultrasound scan to determine eye length and lens power | 15 | $366 | $23 |
| Imaging of optic nerve | 14 | $168 | $12 |
2019: 6 services
| Removal of cataract with insertion of prosthetic lens | 30 | $19,657 | $614 |
| Established patient problem focused exam of visual system | 68 | $3,355 | $39 |
| Established patient complete exam of visual system | 17 | $789 | $46 |
| Exam of visual field with extended testing | 29 | $639 | $21 |
| Measurement of corneal curvature and depth of eye | 23 | $587 | $26 |
| Imaging of optic nerve | 30 | $442 | $14 |
2018: 8 services
| Removal of cataract with insertion of prosthetic lens | 29 | $19,125 | $598 |
| Established patient complete exam of visual system | 72 | $3,875 | $52 |
| Established patient problem focused exam of visual system | 52 | $3,479 | $41 |
| New patient complete exam of visual system | 12 | $825 | $69 |
| Exam of visual field with extended testing | 35 | $757 | $22 |
| Imaging of optic nerve | 35 | $634 | $18 |
| Measurement of corneal curvature and depth of eye | 23 | $527 | $23 |
| Exam of the internal drainage system of eye | 13 | $297 | $17 |
2017: 7 services
| Removal of cataract with insertion of prosthetic lens | 12 | $7,173 | $598 |
| Established patient complete exam of visual system | 71 | $3,671 | $50 |
| Established patient problem focused exam of visual system | 38 | $2,405 | $42 |
| Exam of visual field with extended testing | 29 | $586 | $20 |
| Measurement of corneal curvature and depth of eye | 16 | $473 | $30 |
| Imaging of optic nerve | 29 | $464 | $15 |
| Ultrasound scan to determine eye length and lens power | 12 | $354 | $27 |
2016: 8 services
| Creation of eye fluid drainage tracts in iris using a laser, per session | 16 | $5,375 | $199 |
| Established patient complete exam of visual system | 64 | $3,872 | $58 |
| Established patient problem focused exam of visual system | 52 | $2,816 | $41 |
| Ultrasound scan to determine eye length and lens power | 27 | $727 | $27 |
| Exam of visual field with extended testing | 32 | $595 | $18 |
| Exam of the internal drainage system of eye | 16 | $368 | $18 |
| Imaging of optic nerve | 27 | $362 | $13 |
| Photography of the retina | 11 | $207 | $19 |
2015: 7 services
| Removal of cataract with insertion of prosthetic lens | 24 | $15,692 | $581 |
| Established patient complete exam of visual system | 36 | $2,417 | $64 |
| Established patient problem focused exam of visual system | 38 | $1,629 | $39 |
| Imaging of optic nerve | 41 | $903 | $21 |
| Exam of visual field with extended testing | 41 | $882 | $21 |
| Ultrasound scan to determine eye length and lens power | 27 | $842 | $28 |
| Photography of the retina | 21 | $364 | $17 |
2014: 8 services
| Removal of cataract with insertion of prosthetic lens | 28 | $16,570 | $592 |
| Established patient complete exam of visual system | 74 | $4,410 | $57 |
| Established patient problem focused exam of visual system | 49 | $2,015 | $35 |
| New patient complete exam of visual system | 17 | $977 | $57 |
| Exam of visual field with extended testing | 36 | $669 | $18 |
| Ultrasound scan to determine eye length and lens power | 22 | $565 | $25 |
| Imaging of optic nerve | 28 | $482 | $17 |
| Exam of the internal drainage system of eye | 11 | $160 | $13 |
2013: 9 services
| Removal of cataract with insertion of prosthetic lens | 37 | $22,360 | $604 |
| Established patient complete exam of visual system | 84 | $5,564 | $60 |
| New patient complete exam of visual system | 40 | $2,947 | $74 |
| Established patient problem focused exam of visual system | 49 | $2,548 | $43 |
| Ultrasound scan to determine eye length and lens power | 42 | $938 | $22 |
| Exam of visual field with extended testing | 36 | $881 | $23 |
| Imaging of optic nerve | 30 | $730 | $23 |
| Photography of the retina | 15 | $288 | $19 |
| Exam of the internal drainage system of eye | 14 | $186 | $13 |
Medicaid work
$18,325 in 2024
Medicaid paid $18,325 for 555 billed services this clinician did in 2024, up to 40 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 64 | $15,007 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 362 | $2,602 |
| INTRM OPH EXAM NEW PATIENT | 45 | $370 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 27 | $231 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 14 | $55 |
| Injection, adrenalin, epinephrine, 0.1 mg | 16 | $30 |
| Injection, dexamethasone sodium phosphate, 1 mg | 15 | $17 |
| Cefazolin sodium injection | 12 | $13 |
| 2024 | 555 | 8 | 40 | $18,325 |
| 2023 | 866 | 10 | 48 | $10,728 |
| 2022 | 381 | 2 | 37 | $5,667 |
| 2021 | 69 | 2 | 30 | $1,483 |
| 2020 | 300 | 2 | 37 | $4,590 |
| 2019 | 355 | 3 | 41 | $4,864 |
| 2018 | 338 | 7 | 28 | $2,294 |
See the largest Medicaid services in earlier years
2023
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 84 | $7,903 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 417 | $2,337 |
| Service | 12 | $165 |
| Injection, adrenalin, epinephrine, 0.1 mg | 54 | $124 |
| INTRM OPH EXAM NEW PATIENT | 26 | $119 |
| Injection, dexamethasone sodium phosphate, 1 mg | 46 | $36 |
| Cefazolin sodium injection | 37 | $35 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 12 | $10 |
| Service | 152 | $0 |
| Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) | 26 | $0 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 357 | $3,215 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 24 | $2,453 |
2021
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 13 | $1,086 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 56 | $397 |
2020
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 288 | $2,465 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 12 | $2,124 |
2019
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 327 | $3,494 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 16 | $1,285 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 12 | $85 |
2018
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 178 | $1,049 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 12 | $458 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 80 | $379 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 14 | $206 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 26 | $94 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 15 | $67 |
| Blood glucose (sugar) level | 13 | $41 |
Drugs they prescribed that Part D paid
$44,677
Pharmacies billed $44,677 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 301) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
143 generic and 158 brand-name prescriptions · $44,677 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 53 | $30,141 | $569 |
| Prednisolone Acetate | 95 | $5,635 | $59 |
| Cyclosporine | 17 | $4,919 | $289 |
| Dorzolamide-Timolol | 17 | $1,740 | $102 |
| Moxifloxacin | 15 | $461 | $31 |
See all 9 drugs
| Restasis | 53 | $30,141 | $569 |
| Prednisolone Acetate | 95 | $5,635 | $59 |
| Cyclosporine | 17 | $4,919 | $289 |
| Dorzolamide-Timolol | 17 | $1,740 | $102 |
| Moxifloxacin | 15 | $461 | $31 |
| Dorzolamide-Timolol | 17 | $216 | $13 |
| Ketorolac Tromethamine | 12 | $179 | $15 |
| Latanoprost | 14 | $140 | $10 |
| Acyclovir | 11 | $71 | $6 |
Year by year
| 2024 | 301 | 99 | 0% (0) | 52% | $44,677 |
| 2023 | 216 | 90 | 0% (0) | 57% | $32,511 |
| 2022 | 239 | 76 | 0% (0) | 45% | $28,359 |
| 2021 | 224 | 74 | 0% (0) | 54% | $28,616 |
| 2020 | 229 | 64 | 0% (0) | 42% | $21,025 |
| 2019 | 199 | 68 | 0% (0) | 38% | $17,325 |
| 2018 | 301 | 84 | 0% (0) | 50% | $26,160 |
| 2017 | 364 | 91 | 0% (0) | 51% | $31,708 |
| 2016 | 459 | 118 | None | 55% | $28,945 |
| 2015 | 417 | 121 | 0% (0) | 62% | $28,129 |
| 2014 | 441 | 125 | 0% (0) | None | $24,703 |
| 2013 | 307 | 62 | 0% (0) | None | $13,638 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Restasis | 29 | $17,564 | $606 |
| Cyclosporine | 17 | $6,549 | $385 |
| Prednisolone Acetate | 79 | $5,410 | $68 |
| Moxifloxacin | 12 | $543 | $45 |
| Latanoprost | 16 | $216 | $14 |
2022: 7 drugs
| Restasis | 20 | $12,061 | $603 |
| Prednisolone Acetate | 74 | $5,111 | $69 |
| Dorzolamide | 11 | $513 | $47 |
| Moxifloxacin | 17 | $488 | $29 |
| Latanoprost | 26 | $293 | $11 |
| Timolol Maleate | 15 | $168 | $11 |
| Ketorolac Tromethamine | 11 | $163 | $15 |
2021: 5 drugs
| Restasis | 34 | $17,707 | $521 |
| Prednisolone Acetate | 70 | $5,693 | $81 |
| Latanoprost | 22 | $364 | $17 |
| Timolol Maleate | 20 | $282 | $14 |
| Brimonidine | 12 | $67 | $6 |
2020: 6 drugs
| Restasis | 23 | $10,782 | $469 |
| Prednisolone Acetate | 59 | $5,020 | $85 |
| Brimonidine | 21 | $521 | $25 |
| Timolol Maleate | 24 | $428 | $18 |
| Acyclovir | 11 | $371 | $34 |
| Latanoprost | 29 | $316 | $11 |
2019: 5 drugs
| Restasis | 18 | $8,436 | $469 |
| Prednisolone Acetate | 37 | $2,993 | $81 |
| Latanoprost | 34 | $468 | $14 |
| Timolol Maleate | 34 | $306 | $9 |
| Acyclovir | 17 | $235 | $14 |
2018: 7 drugs
| Restasis | 24 | $11,867 | $494 |
| Prednisolone Acetate | 79 | $5,538 | $70 |
| Alphagan P | 13 | $2,233 | $172 |
| Latanoprost | 49 | $785 | $16 |
| Timolol Maleate | 41 | $346 | $8 |
| Dorzolamide | 13 | $279 | $21 |
| Acyclovir | 14 | $171 | $12 |
2017: 6 drugs
| Restasis | 66 | $19,283 | $292 |
| Prednisolone Acetate | 82 | $5,821 | $71 |
| Brimonidine | 13 | $1,036 | $80 |
| Latanoprost | 63 | $899 | $14 |
| Dorzolamide | 18 | $342 | $19 |
| Timolol Maleate | 36 | $239 | $7 |
2016: 9 drugs
| Restasis | 24 | $6,320 | $263 |
| Travatan Z | 28 | $5,052 | $180 |
| Prednisolone Acetate | 81 | $4,945 | $61 |
| Brimonidine | 29 | $3,211 | $111 |
| Latanoprost | 106 | $1,143 | $11 |
| Pred Forte | 22 | $953 | $43 |
| Timolol Maleate | 50 | $374 | $7 |
| Dorzolamide | 15 | $352 | $23 |
| Acyclovir | 12 | $232 | $19 |
2015: 7 drugs
| Prednisolone Acetate | 104 | $6,750 | $65 |
| Travatan Z | 46 | $6,749 | $147 |
| Restasis | 19 | $4,009 | $211 |
| Brimonidine | 24 | $2,426 | $101 |
| Latanoprost | 69 | $884 | $13 |
| Dorzolamide | 25 | $660 | $26 |
| Timolol Maleate | 64 | $622 | $10 |
2014: 7 drugs
| Prednisolone Acetate | 101 | $6,337 | $63 |
| Travatan Z | 41 | $4,778 | $117 |
| Alphagan P | 16 | $3,331 | $208 |
| Dorzolamide | 41 | $1,228 | $30 |
| Latanoprost | 80 | $1,098 | $14 |
| Timolol Maleate | 72 | $693 | $10 |
| Flurbiprofen | 41 | $313 | $8 |
2013: 7 drugs
| Travatan Z | 30 | $3,123 | $104 |
| Brimonidine | 25 | $2,999 | $120 |
| Dorzolamide | 31 | $1,226 | $40 |
| Prednisolone Acetate | 44 | $970 | $22 |
| Latanoprost | 57 | $813 | $14 |
| Timolol Maleate | 61 | $465 | $8 |
| Flurbiprofen | 21 | $181 | $9 |
Money from drug and device companies
$175 in 2025
| 2025 | 2 | 2 | None | $175 |
| 2024 | 3 | 5 | None | $444 |
| 2023 | 2 | 4 | None | $405 |
| 2022 | 1 | 1 | None | $99 |
| 2020 | 2 | 2 | None | $200 |
| 2019 | 1 | 2 | None | $211 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech | Susvimo | $144 | 1 payment
|
| Alcon Vision | Clareon | $31 | 1 payment
|
See all 2 published payments
| Genentech | Meals · 2025-07-17 | Susvimo | $144 |
| Alcon Vision | Meals · 2025-05-21 | Clareon | $31 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $444
| Alcon Vision | Argos | $276 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $146 | 1 payment
|
| KLS-Martin L.P. | None | $22 | 1 payment
|
2023: $405
| Alcon Vision | Clareon | $386 | 3 payments
|
| Bausch & Lomb Americas | Envista Mx60 Iol | $19 | 1 payment
|
2022: $99
| Alcon Vision | Clareon | $99 | 1 payment
|
2020: $200
| Alcon Vision | Acrysof Iq Panoptix | $164 | 1 payment
|
| Genzyme | Fabrazyme | $35 | 1 payment
|
2019: $211
| Alcon Vision | Centurion | $211 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1942264858
- Licence
- CA A53636California A53636: Current · expires 2028-03-31
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A536360
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-04-17
- NPI last updated
- 2007-09-12
This is when the NPI record was last certified, not a medical board exam.